TGFB1 and lung carcinoma: Next, we treated the HFL1 cells with miR-574-5p oe sEV or ScrC sEV derived from the neuroblastoma cell lines SK-N-AS and SK-N-SH and the lung cancer cell lines A549 and 2106T, combined with and without TGF-β stimulation.